Diseases,
Journal Year:
2024,
Volume and Issue:
12(12), P. 313 - 313
Published: Dec. 3, 2024
Background/Objectives:
Despite
advancements
in
antiretroviral
therapy
(ART),
HIV-positive
individuals
face
heightened
risks
of
cardiovascular
and
gastrointestinal
(GI)
complications,
often
linked
to
persistent
systemic
inflammation.
Left
ventricular
diastolic
dysfunction
(LVDD),
prevalent
HIV
patients,
exacerbates
this
inflammatory
state
may
contribute
worsened
GI
symptoms.
This
study
aims
explore
the
association
between
LVDD,
inflammation,
symptoms
patients
undergoing
ART.
The
primary
objective
is
analyze
how
LVDD
contributes
burden
its
impact
on
health
population.
Methods:
cross-sectional
included
320
participants
divided
into
three
groups:
with
(n
=
80),
without
120),
HIV-negative
controls
120).
Levels
biomarkers—CRP,
IL-6,
TNF-α,
fibrinogen,
IL-1β,
IFN-γ,
D-dimer—were
measured,
were
assessed.
Echocardiographic
evaluations
performed
determine
presence
severity,
while
multivariate
logistic
regression
identified
predictors
complications.
Results:
Patients
+
group
exhibited
significantly
elevated
levels
CRP,
D-dimer
compared
other
groups,
correlating
higher
incidences
nausea,
diarrhea,
abdominal
pain.
TNF-α
emerged
as
strongest
predictor
symptoms,
underscoring
role
pathophysiology
linking
distress
Persistent
inflammation
coagulation
abnormalities
ART
suggest
that
alone
not
fully
mitigate
these
Conclusions:
Our
findings
emphasize
compounded
highlighting
need
for
integrated
approaches
address
both
Anti-inflammatory
therapies
targeting
specific
biomarkers
like
could
improve
clinical
outcomes,
supporting
a
more
comprehensive
strategy
managing
HIV-related
comorbidities
beyond
viral
suppression.
Cureus,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 15, 2025
The
increasing
lifespan
of
people
living
with
HIV
(PLWH)
due
to
advancements
in
antiretroviral
therapy
(ART)
has
shifted
mortality
patterns
from
AIDS-related
non-AIDS-related
causes,
notably
cardiovascular
diseases
(CVDs).
This
review
investigates
how
and
ART
contribute
vascular
endothelial
dysfunction,
myocardial
fibrosis,
hypercoagulation,
which
significantly
exacerbate
risk.
Mechanistic
insights
include
chronic
inflammation
immune
dysregulation
persistent
infection
ART-specific
effects
such
as
protease
inhibitors
causing
dyslipidemia
zidovudine
inducing
mitochondrial
toxicity
leading
cardiomyopathy.
ART,
while
lifesaving,
been
implicated
promoting
subclinical
atherosclerosis
the
risk
acute
infarction,
further
highlighting
need
for
tailored
approaches.
manuscript
addresses
pressing
obstacles,
including
disparities
healthcare
access
lack
standardized
screening
guidelines
specific
PLWH.
It
emphasizes
integration
advanced
imaging
techniques
emerging
biomarkers,
coronary
artery
calcium
scoring
soluble
ST2,
detect
early
abnormalities.
also
identifies
challenges
selection
balance
virologic
control
safety.
What
sets
this
apart
is
its
holistic
detailed
approach
intersection
health.
not
only
elucidates
complex
pathophysiological
mechanisms
but
offers
actionable
into
current
clinical
fall
short.
underscores
urgency
implementing
proactive
protocols
PLWH
refining
regimens
mitigate
CVD
risks.
By
addressing
these
gaps,
work
aims
expand
our
understanding
HIV-related
manifestations
provide
a
foundation
targeted
interventions,
thereby
improving
long-term
health
outcomes
comprehensive
perspective
poised
transform
practice
by
fostering
greater
awareness
among
physicians
encouraging
development
more
effective
strategies
managing
risks
population.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(4), P. 1708 - 1708
Published: Feb. 17, 2025
The
endothelium
is
pivotal
in
multiple
physiological
processes,
such
as
maintaining
vascular
homeostasis,
metabolism,
platelet
function,
and
oxidative
stress.
Emerging
evidence
the
past
decade
highlighted
immunomodulatory
function
of
endothelium,
serving
a
link
between
innate,
adaptive
immunity
inflammation.
This
review
examines
regulation
immune-inflammatory
axis
by
discusses
immune
functions,
explores
pathophysiological
processes
leading
to
endothelial
dysfunction
various
metabolic
disturbances,
including
hyperglycemia,
obesity,
hypertension,
dyslipidaemia.
final
section
focuses
on
novel,
repurposed,
emerging
therapeutic
targets
that
address
dysfunction.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: Feb. 28, 2025
Introduction
Pyroptosis
is
an
important
inflammatory
form
of
cell
death
and
Mycobacterium
tuberculosis
(
M.tb
)
chronic
infection
triggers
excessive
pyroptosis
macrophages.
Our
previous
research
has
confirmed
that
a
small
compound
pyrvinium
pamoate
(PP)
could
inhibit
pathological
changes
mycobacterial
burden
in
-infected
mice,
but
the
potential
mechanism
PP
for
inhibiting
-induced
inflammation
remains
unexplored.
Methods
The
effects
on
NLRP3-ASC-Casp1
inflammasome
assembly
activation,
gasdermin
D
(GSDMD)
mediated
cytokines
expression
were
assessed
human
THP-1-derived
macrophages
after
H37Rv/H37Ra/
Salmonella
typhimurium
S.
or
LPS
treatment
by
Transcriptome
sequencing,
RT-qPCR,
Co-immunoprecipitation
Western
Blot
(WB)
analysis.
lactate
dehydrogenase
(LDH)
release
assay
was
used
to
evaluate
CC50
THP-1
cells.
Results
We
found
/
significantly
activate
GSDMD-mediated
(IL-1β
IL-18)
macrophages,
whereas
suppress
these
dose
dependent
manner.
Regarding
PP-inhibition
mechanism,
we
further
this
inhibitory
activity
through
PP-targeting
casein
kinase
1A1
(CK1α)–β-catenin–NF-κB
pathway
CK1α–NRF2–mitochondrial
oxidative
phosphorylation
(OXPHOS)
pathway.
In
addition,
CK1α
specific
inhibitor
D4476
siRNA
reverse
bacteria-induced
responses
Conclusions
This
study
reveals
previously
unreported
can
NLRP3
GSDMD–IL-1β
via
targeting
suppressing
CK1α–β-catenin–NF-κB
OXPHOS
pathways,
suggesting
holds
great
promise
as
host
directed
therapy
(HDT)
drug
mycobacterial-induced
response.
Abstract
Recent
research
has
shown
that
metabolic
processes
within
immune
cells
are
essential
for
both
human
immunodeficiency
virus
1
(HIV-1)
infection
and
the
response.
Throughout
HIV-1
infection—from
acute
stages
to
chronic
viral
latency—immune
experience
shifts
in
energy
demands
pathways,
paralleling
T-cell
exhaustion.
Dysregulated
metabolism
compromises
cell
function,
leading
dysfunction
persistent
inflammation.
Therefore,
alterations
constitute
a
critical
mechanism
progression
This
review
specifically
explores
profiles
roles
of
T
cells,
monocytes-macrophages,
dendritic
natural
killer
B
at
different
infection,
emphasizing
effects
on
pathways
diverse
types.
These
insights
offer
valuable
therapeutic
strategies
aimed
inhibiting
replication,
restoring
controlling
disease
progression.
HIV Research & Clinical Practice,
Journal Year:
2025,
Volume and Issue:
26(1)
Published: March 18, 2025
People
with
HIV
are
at
increased
risk
of
cardiovascular
events;
thus,
care
delivery
strategies
that
increase
access
to
comprehensive
disease
(CVD)
management
a
priority.
We
report
the
results
multi-component
telemedicine-based
strategy
improve
blood
pressure
control
among
people
HIV—Assess
and
Adapt
Impact
COVID-19
on
CVD
Self-Management
Prevention
Care
in
Adults
Living
(AAIM-High).
The
AAIM
High
is
virtual
adaptation
our
previously
published
EXTRA-CVD
consisted
hypertension
education
six
components:
nurse-led
coordination
(delivered
by
teleconference
or
telephone),
home
systolic
(SBP)
monitoring,
evidence-based
treatment
algorithms,
electronic
health
records
tools,
technology
coach,
communication
preferences
assessment.
(n
=
74)
comorbid
three
academic
medical
centers
were
enrolled
single
arm
implementation
study
from
January
2021
December
2022.
Over
12
months,
average
patient-performed
SBP
decreased
7.7
mmHg
(95%
CI
−11.5,
−3.9).
percentage
patients
goal,
defined
as
<130
mmHg,
46.0%
72.5%
months.
By
adapting
growing
use
telemedicine
healthcare
delivery,
effectively
improved
through
virtual,
intervention.
Molecular and Cellular Biochemistry,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 26, 2025
In
clonal
hematopoiesis
of
indeterminate
potential
(CHIP),
subpopulations
blood
cells
carrying
somatic
mutations
expand
as
the
individual
ages,
and
this
expansion
may
elevate
risk
cancers
well
cardiovascular
disease.
Individuals
at
higher
CHIP
therefore
CHIP-associated
disease
can
be
identified
through
mutational
profiling,
apparently
central
role
inflammation
in
has
emerged
a
therapeutic
target.
While
is
often
associated
with
negative
health
outcomes,
emerging
evidence
suggests
that
some
CHIP-related
also
exert
beneficial
effects,
indicating
more
complex
human
health.
This
review
examines
current
understanding
epidemiology
clinical
significance
driving
its
association
risk.
It
explores
mechanisms
linking
to
other
diseases,
personalizing
therapies
against
those
diseases
for
individuals
CHIP.
Viruses,
Journal Year:
2025,
Volume and Issue:
17(4), P. 547 - 547
Published: April 8, 2025
People
living
with
HIV
(PLWH)
develop
cardiovascular
diseases
(CVDs)
about
a
decade
earlier
and
at
rates
2–3
times
higher
than
the
general
population.
At
present,
pharmacological
strategies
to
delay
onset
of
CVDs
in
PLWH
are
unavailable,
part
because
an
incomplete
understanding
its
molecular
causes.
We
others
recently
uncovered
elevated
levels
toxic
glycolysis
inflammation-induced
byproduct
methylglyoxal
(MG)
plasma
from
HIV-infected
humanized
mice
(Hu-mice).
also
found
reduction
expression
primary
MG-degrading
enzyme
glyoxalase
I
(Glo-I)
autopsied
cardiac
tissues
HIV-1-infected
individuals
Hu-mice.
Increasing
Glo-I
Hu-mice
not
only
attenuated
heart
failure
but
reduced
endothelial
cell
damage,
increased
density
perfused
microvessels,
prevented
microvascular
leakage
micro-ischemia,
blunted
protein
vascular
protein-1
(VAP-1),
key
mediators
CVDs.
In
this
narrative
review,
we
posit
that
MG
is
contributing
cause
for
early
PLWH.
Pharmacological
prevent
accumulation
development
early-onset
discussed.
Antioxidants,
Journal Year:
2024,
Volume and Issue:
14(1), P. 38 - 38
Published: Dec. 31, 2024
Oxidative
stress
plays
a
pivotal
role
in
the
pathogenesis
and
progression
of
cardiovascular
diseases
(CVDs).
This
review
focuses
on
signaling
pathways
oxidative
during
development
CVDs,
delving
into
molecular
regulatory
networks
underlying
various
disease
stages,
particularly
apoptosis,
inflammation,
fibrosis,
metabolic
imbalance.
By
examining
dual
roles
influences
sex
differences
levels
susceptibility,
this
study
offers
comprehensive
understanding
diseases.
The
integrates
key
findings
from
current
research
three
ways.
First,
it
outlines
major
CVDs
associated
with
their
respective
pathways,
emphasizing
stress’s
central
pathology.
Second,
summarizes
protective
effects,
mechanisms
action,
animal
models
antioxidants,
offering
insights
future
drug
development.
Third,
discusses
applications,
advantages,
limitations,
potential
targets
gene
therapy
providing
foundation
for
novel
therapeutic
strategies.
These
tables
underscore
systematic
integrative
nature
while
theoretical
basis
precision
treatment
CVDs.
A
contribution
is
differential
effects
across
different
stages
addition
to
proposal
innovative,
multi-level
intervention
strategies,
which
open
new
avenues
system.
The Journal of Infectious Diseases,
Journal Year:
2024,
Volume and Issue:
231(2), P. e407 - e418
Published: Dec. 4, 2024
Persons
with
HIV
(PWH)
on
contemporary
antiretroviral
therapy
(ART)
are
at
elevated
risk
for
developing
age-related
cardiometabolic
diseases.
We
hypothesized
that
integrative
analysis
of
cross-tissue,
multimodal
data
from
PWH
could
provide
insight
into
molecular
programming
defines
phenotypes
in
this
high-risk
group.
enrolled
93
without
diabetes
who
were
virologically
suppressed
ART
and
obtained
measures
insulin
resistance,
glucose
intolerance,
adiposity.
performed
circulating
lipidomics,
proteomics,
metabolomics,
as
well
subcutaneous
adipose
tissue
(SAT)
bulk
transcriptomics,
used
multiomics
factor
(MOFA)
to
perform
analyses
these
datasets.
The
median
age
was
43
years,
body
mass
index
30.8
kg/m2,
81%
male,
56%
self-identified
non-Hispanic
White.
identified
a
specific
MOFA
associated
visceral
volume
(ρ
=
-0.43),
homeostasis
model
assessment
2
resistance
score
-0.52),
liver
density
0.43),
other
factors,
which
explained
more
variance
the
SAT
transcriptome
lipidome
compared
proteome
metabolome.
Gene
set
enrichment
showed
extracellular
matrix
inflammatory
pathways
primarily
mapped
myeloid
cells
progenitor
using
single-cell
deconvolution.
Lipidomic
significantly
enriched
triacylglycerol
diacylglycerol
species.
Our
multiomic
demonstrated
coordinated,
multitissue
reprogramming
disease
risk.
Longitudinal
studies
assessments
lipid
handling
necessary
understand
mechanisms
PWH.
Clinical
Trials
Registration.
NCT04451980.
Viruses,
Journal Year:
2024,
Volume and Issue:
16(12), P. 1938 - 1938
Published: Dec. 18, 2024
Metformin,
a
widely
used
antidiabetic
medication,
has
emerged
as
promising
broad-spectrum
antiviral
agent
due
to
its
ability
modulate
cellular
pathways
essential
for
viral
replication.
By
activating
AMPK,
metformin
depletes
energy
reserves
that
viruses
rely
on,
effectively
limiting
the
replication
of
pathogens
such
influenza,
HIV,
SARS-CoV-2,
HBV,
and
HCV.
Its
role
in
inhibiting
mTOR
pathway,
crucial
protein
synthesis
reactivation,
is
particularly
significant
managing
infections
caused
by
CMV,
EBV.
Furthermore,
reduces
oxidative
stress
reactive
oxygen
species
(ROS),
which
are
critical
replicating
arboviruses
Zika
dengue.
The
drug
also
regulates
immune
responses,
differentiation,
inflammation,
disrupting
life
cycle
HPV
potentially
other
viruses.
These
diverse
mechanisms
suppress
replication,
enhance
system
functionality,
contribute
better
clinical
outcomes.
This
multifaceted
approach
highlights
metformin’s
potential
an
adjunctive
therapy
treating
wide
range
infections.